The largest database of trusted experimental protocols

7 protocols using nadph regenerating system

1

Liver Microsome and Plasma Stability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver microsomes (Human or CD-1 mouse) were diluted to 0.5 mg/mL in a solution containing 100 mM PBS buffer at pH 7.4, an NADPH regenerating system (Promega), and test compounds and control compounds were diluted from DMSO stock solutions to 1 µM, unless otherwise indicated. Control reactions were made by withholding the addition of the NADPH regenerating solution, which enabled us to assess whether compound stability was the result of NADPH-dependent metabolism. The mixture was incubated at 37 °C under gentle rotation and quenched by aliquoting 10 µL of solution into 90 µL ice-cold acetonitrile containing an internal standard. To evaluate the plasma stability of lead compounds, plasma (Human or CD-1 mouse) was warmed to 37 °C in a water bath, and test compounds were added to the plasma at 10 µM. Plasma samples were incubated at 37 °C under gentle rotation. At indicated time points, samples were quenched by aliquoting 10 µL of solution into 90 µL ice-cold acetonitrile containing an internal standard. Samples were collected and analyzed by LC-MS on a Waters H-Class Plus UPLC connected to a Xevo G2-XS QTOF mass spectrometer running in ESI+ mode. The method used a Waters Acquity UPLC BEH C18 (2.1 × 50 mm, 1.7 µm) column with a gradient of 23–100% B (A: water + 0.2% formic acid, B: 4:1 methanol/isopropanol).
+ Open protocol
+ Expand
2

Intrinsic Clearance of Compounds 1 and 2

Check if the same lab product or an alternative is used in the 5 most similar protocols
The intrinsic clearance (CLint) of compounds 1 and 2 was determined using mouse (CD-1) liver microsomes (Gibco). Briefly, microsomes (100 μg final protein concentration) and test compound in 0.1 M phosphate buffer, pH 7.4, were prepared. In parallel, an NADPH-regenerating system (Promega) was prepared in 0.1 M phosphate buffer (pH 7.4). The solutions were pre-incubated at 37°C for 10 min before assessment of the CLint was initiated by mixing the two solutions (50 μL of each; final compound concentration 1 μg·mL) at 37°C. After 0, 5, 10, 15, 20 and 30 min, the reactions were terminated by the addition of 100 μL of acetonitrile containing 1 μg·mL−1 verapamil and placed on ice for 30 min. The samples were then centrifuged at 12 000× g for 10 min and analysed by LC–MS to determine the quantity of the parent compound remaining over time. Carbamazepine (1 μg·mL−1) was used as a control for low CLint.
+ Open protocol
+ Expand
3

Enzymatic Activity of CYP2J2 in Yeast

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FinePure Universal DNA Purification Kit was purchased from GENFINE (Beijing, China). The CYP2J2 Human Tagged ORF Clone (RC207417) was purchased from Origene (United States). Saccharomyces cerevisiae strain YPH499 was obtained from ATCC (VA, United States). The yeast expression vector pESC-URA was purchased from Stratagene (United States). The following primary antibodies were used: rabbit polyclonal anti-CYP2J2 antibody (Abcam, United Kingdom), mouse monoclonal anti-OR antibody (Santa Cruz Biotechnology, United States) and corresponding secondary antibodies (Proteintech, China). Ebastine and terfenadine were purchased from Tokyo Chemical Industry. HydroxyEbastine, terfenadine alcohol and midazolam were purchased from Santa Cruz and TRC. The NADPH-regenerating system was purchased from Promega (United States). High-pressure liquid chromatography-grade solvents were purchased from Fisher Scientific Co., (United States). All the other chemicals and solvents were commercially available at analytical grade or the highest grade.
+ Open protocol
+ Expand
4

Silica Particle Inhibition of LIPA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The inhibitory effects of silica particles at various concentrations (2, 10, 50, 200, and 800 μg/mL) and ketoconazole (200 nmol/L) were determined with HLMs (20 μg/mL) in the presence of NADPH Regenerating System (Promega). The incubation mixtures, which consisted of silica particles, ketoconazole, 10 μmol/L LIPA, and HLMs in potassium phosphate buffer (15 μL, respectively), were pre-incubated for 10 min at 37°C, and then the enzymatic reactions were initiated by the addition of 15 μL of NADPH. In addition, to determine whether LIPA was physically bound to the silica particles, we also started the reaction by adding 15 μL of LIPA after preparing a mixture of the silica particles, HLMs, buffer, and NADPH. Next, to determine whether the silica particles were physically bound to microsome proteins, we centrifuged a mixture of silica particles, LIPA, HLMs, and buffer at 1,000 × g or 5,000 × g for 20 min and then added NADPH (15 μL) to the supernatant (45 μL). For each of these procedures, the reactions were terminated after 10 min of incubation by the addition of reconstitution buffer (60 μL). Each plate was incubated at room temperature for 20 min, and then the luminescence was read with a luminometer for 1 s per well.
+ Open protocol
+ Expand
5

Yeast-based CYP3A4 Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FinePure Universal DNA Purification Kit was supplied by GENFINE Biotech in Beijing, China. Taq plus master mix was purchased from Vazyme (Nanjing, China). Restriction enzymes, along with DO Supplement-Ura, all purchased from Takara Bio, Inc (Otsu, Shiga, Japan). Yeast strain YPH499 was obtained from the American Type Culture Collection (ATCC) in Virginia, USA. The growth mediums for yeast, specifically the yeast nitrogen base devoid of amino acids, along with dextrose, galactose, and MDZ, were supplied by Sigma-Aldrich (Missouri, USA). The rabbit polyclonal anti-CYP3A4 antibody was obtained from Abcam (Cambridge, UK) and the mouse monoclonal anti-OR antibody was from Santa Cruz Biotechnology in Dallas, Texas, USA.
The chemical 1-hydroxy Midazolam (1'-OH-MDZ) was obtained from Toronto Research Chemicals, Inc. (Toronto, Ontario, Canada). The NADPH-regenerating system was purchased from Promega in Madison, Wisconsin, USA. The Super Signal West Pico Trial Kit and highpressure liquid chromatography-grade solvents were acquired from Thermo Fisher Scientific Co.
in Waltham, Massachusetts, USA. All other chemicals and solvents used in our experiments were of the highest purity and analytical grade available on the market.
+ Open protocol
+ Expand
6

Baculovirus-Mediated Recombinant Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Materials and kits were purchased from the following sources: TIANamp Blood DNA Midi Kit (TIANGEN, Beijing, China); PrimeSTAR HS DNA polymerase and restriction enzymes (Takara Bio, Inc.; Otsu, Shiga, Japan); Spodoptera frugiperda (Sf)21 insect cells, Sf-900TM III SFM insect culture medium and Bac to-Bac Baculovirus Expression System (Invitrogen, Carlsbad, CA, United States); Mouse monoclonal anti-OR antibody (Santa Cruz Biotechnology, Dallas, Texas, United States); Rabbit polyclonal anti-CYP2C9 antibody (Abcam, Cambridge, United Kingdom); Super Signal West Pico Trial Kit (Thermo Scientific, Rockford, IL, United States); 4-Hydroxytolbutamide, 4-hydroxydiclofenac, and telmisartan (Toronto Research Chemicals, Inc.; Toronto, Ontario, Canada); Diclofenac and chlorpropamide (Tokyo Chemical Industry Co., Ltd.; Tokyo, Japan); Tolbutamide, losartan and E-3174 (Sigma-Aldrich, St. Louis, MO, United States); NADPH-regenerating system (Promega, Madison, WI, United States); High-pressure liquid chromatography-grade solvents (Fisher Scientific Co.; Fair Lawn, NJ, United States). All other chemicals and reagents were of analytical grade or the highest commercially available quality.
+ Open protocol
+ Expand
7

Hepatic Clearance of Compounds 1 and 2

Check if the same lab product or an alternative is used in the 5 most similar protocols
The intrinsic clearance (CLint) of compounds 1 and 2 was determined using mouse (CD‐1) liver microsomes (Gibco). Briefly, microsomes (100 μg final protein concentration) and test compound in 0.1 M phosphate buffer, pH 7.4, were prepared. In parallel, an NADPH‐regenerating system (Promega) was prepared in 0.1 M phosphate buffer (pH 7.4). The solutions were pre‐incubated at 37°C for 10 min before assessment of the CLint was initiated by mixing the two solutions (50 μL of each; final compound concentration 1 μg·mL) at 37°C. After 0, 5, 10, 15, 20 and 30 min, the reactions were terminated by the addition of 100 μL of acetonitrile containing 1 μg·mL−1 verapamil and placed on ice for 30 min. The samples were then centrifuged at 12 000× g for 10 min and analysed by LC–MS to determine the quantity of the parent compound remaining over time. Carbamazepine (1 μg·mL−1) was used as a control for low CLint.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!